Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Trial for the Establishment of Controlled Human Malaria Infection by Bites of Plasmodium Falciparum-infected Anopheles Gambiae in Lambaréné

NCT07816497 is registered in ClinicalTrials.gov with Centre de Recherche Médicale de Lambaréné as lead sponsor.

NCT NCT07816497
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07816497 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Trial for the Establishment of Controlled Human Malaria Infection by Bites of Plasmodium Falciparum-infected Anopheles Gambiae in Lambaréné
Lead sponsor
Centre de Recherche Médicale de Lambaréné
Phase
Phase 1
Overall status
Completed
Start date
July 18, 2025
Completion date
February 19, 2026
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malaria (plasmodium falciparum)